Delivery Order SPE2DB20D1109-SPE2DB25FP78J
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract with a ceiling value of $11,565.51. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with performance occurring at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a contract ceiling value of $4,100.20. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) valued at $10,167.10 under a firm fixed-price contract type. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $1,117.09. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on January 10, 2025, with a ceiling value of $1,726.39 and an ultimate completion date of January 13, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and represents a direct procurement of pharmaceutical products to support federal medical supply needs. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a contract ceiling value of $2,300.88. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $5,576.57. This competitive, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP78JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on September 17, 2025, with a contract ceiling value of $14,041.92 and ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical delivery under the company's broader federal contracting relationship with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves critical federal medical procurement needs for military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's history of competitively awarded contracts demonstrates its capability to fulfill federal healthcare requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 9/17/25 |